文献速递免疫规划传染病防控与疫情报告

PCV疫苗对成人肺炎球菌实验攻击的保护作用主要由控制定植密度介导

Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density.
PubMed 文献 · Vaccine · 2019-06-05

基于实验性人类肺炎球菌攻击(EHPC)模型的双盲随机对照试验,采用多重qPCR复评志愿者定植状态发现,PCV-13对定植获得的保护效力从经典培养的83%降至29%,但对已定植者的定植密度有显著降低作用,提示PCV疫苗成功主要可能由控制定植密度介导。

要点

  • PCV-13对定植获得的保护效力因检测方法而异,qPCR为29%,经典培养为83%。
  • PCV对实验定植志愿者的定植密度有显著降低作用。
  • 评估肺炎球菌疫苗影响的研究应在设计中纳入密度测量。

核心结论

  • 在成人中获得的这些结果提示,PCV疫苗接种的成功主要可能由控制定植密度介导。

研究设计与样本

  • 采用实验性人类肺炎球菌攻击(EHPC)模型的双盲随机对照试验,使用靶向lytA和血清型6A/B cpsA基因的多重qPCR assay复评同一批志愿者的定植状态。

主要发现

  • qPCR检测低密度定植增加导致PCV对定植获得的效力降至29%,而经典培养为83%。
  • 对于实验定植的志愿者,PCV对降低定植密度有显著作用。

关键数值与推荐

  • PCV-13(Prevenar-13)对定植获得的保护效力:经典培养为83%,qPCR为29%。

临床怎么用

  • 评估肺炎球菌疫苗影响的研究应在设计中允许进行定植密度测量。

局限性

  • 结果基于成人EHPC模型,向其他人群和自然定植场景的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Widespread use of Pneumococcal Conjugate Vaccines (PCV) has reduced vaccine-type nasopharyngeal colonisation and invasive pneumococcal disease. In a double-blind, randomised controlled trial using the Experimental Human Pneumococcal Challenge (EHPC) model, PCV-13 (Prevenar-13) conferred 78% protection against colonisation acquisition and reduced bacterial intensity (AUC) as measured by classical culture. We used a multiplex qPCR assay targeting lytA and pneumococcal serotype 6A/B cpsA genes to re-assess the colonisation status of the same volunteers. Increase in detection of low-density colonisation resulted in reduced PCV efficacy against colonisation acquisition (29%), compared to classical culture (83%). For experimentally colonised volunteers, PCV had a pronounced effect on decreasing colonisation density. These results obtained in adults suggest that the success of PCV vaccination could primarily be mediated by the control of colonisation density. Studies assessing the impact of pneumococcal vaccines should allow for density measurements in their design.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. German EL, Solórzano C, Sunny S, et al. Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density. Vaccine. 2019. PMID: 31176540. doi:10.1016/j.vaccine.2019.05.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。